Literature DB >> 35862703

Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

R C A de Groot1, H Zhu1, T Hoogenboezem1, A C J M de Bruijn1, E Eenjes2, A E J 't Jong3, A I Belo1, S C Estevão1, J J Bajramovic3, R J Rottier2, M Kool4, A M C van Rossum5, W W J Unger1.   

Abstract

Mycoplasma pneumoniae and Streptococcus pneumoniae are the most common bacterial causes of pneumonia in children. The clinical characteristics of pneumonia differ significantly between the two bacteria. We aimed to elucidate the differences in pathogenesis between M. pneumoniae and S. pneumoniae by characterizing the respiratory epithelial cell immune response to both pathogens. Using primary human bronchial epithelial cells in air-liquid interface cultures, we observed lower production of the proinflammatory cytokines interleukin-6 (IL-6) and IL-8 in response to M. pneumoniae than to S. pneumoniae. In contrast to the differences in proinflammatory cytokine production, Toll-like receptor 2 (TLR2)-mediated signaling in response to M. pneumoniae was stronger than to S. pneumoniae. This difference largely depended on TLR1 and not TLR6. We found that M. pneumoniae, but not S. pneumoniae, also induced signaling of TLR10, a coreceptor of TLR2 that has inhibitory properties. M. pneumoniae-induced TLR10 signaling on airway epithelial cells was partially responsible for low IL-8 production, as blocking TLR10 by specific antibodies increased cytokine production. M. pneumoniae maintained Th2-associated cytokine production by epithelial cells, which concurs with the known association of M. pneumoniae infection with asthma. M. pneumoniae left IL-33 levels unchanged, whereas S. pneumoniae downregulated IL-33 production both under homeostatic and Th2-promoting conditions. By directly comparing M. pneumoniae and S. pneumoniae, we demonstrate that M. pneumoniae avoids induction of proinflammatory cytokine response despite its ability to induce robust TLR2 signaling. Our new findings suggest that this apparent paradox may be partially explained by M. pneumoniae-induced signaling of TLR2/TLR10.

Entities:  

Keywords:  IL-33; IL-8; Mycoplasma pneumoniae; Streptococcus pneumoniae; TLR10; TLR2; host response; pneumonia; primary bronchial epithelial cells; respiratory pathogens

Mesh:

Substances:

Year:  2022        PMID: 35862703      PMCID: PMC9387261          DOI: 10.1128/iai.00129-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  49 in total

Review 1.  Innate immunity in the lung: how epithelial cells fight against respiratory pathogens.

Authors:  R Bals; P S Hiemstra
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

2.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

3.  Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1.

Authors:  Maria Manukyan; Kathy Triantafilou; Martha Triantafilou; Alan Mackie; Nadra Nilsen; Terje Espevik; Karl-Heinz Wiesmüller; Artur J Ulmer; Holger Heine
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

4.  Effect of Mycoplasma pneumoniae lysate on interleukin-8 gene expression in human respiratory epithelial cells.

Authors:  Myung Hyun Sohn; Kyung Eun Lee; Sung Yon Choi; Byoung Chul Kwon; Myung Woong Chang; Kyu-Earn Kim
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

5.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Authors:  A Yoshimura; E Lien; R R Ingalls; E Tuomanen; R Dziarski; D Golenbock
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

6.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

7.  Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.

Authors:  Jin Young Kang; Xuehua Nan; Mi Sun Jin; Suk-Jun Youn; Young Hee Ryu; Shinjee Mah; Seung Hyun Han; Hayyoung Lee; Sang-Gi Paik; Jie-Oh Lee
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

Review 8.  The CC chemokine CCL20 and its receptor CCR6.

Authors:  Evemie Schutyser; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

9.  Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen.

Authors:  María A Meseguer; Alberto Alvarez; María T Rejas; Carlos Sánchez; José C Pérez-Díaz; Fernando Baquero
Journal:  Infect Genet Evol       Date:  2003-05       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.